Neutrophils are phagocytic white blood cells, and a deficiency of their numbers (""""""""neutropenia"""""""") predisposes to bacterial and fungal infection. The two principal inherited forms of human neutropenic bone marrow failure are cyclic neutropenia (CN) and leukemia-predisposing, severe congenital neutropenia (SCN). """"""""Benign ethnic neutropenia"""""""" is common to individuals of African descent and may also have health consequences. Mutations of the gene ELA2, encoding neutrophil elastase (NE), cause CN and are the most frequent cause of SCN. Recent findings that canine CN is caused by mutations of the AP3 transporter and that some SCN may result from ELA2 promoter variants or mutations of the transcriptional repressor Gfi1, both of which lead to over-expression of NE, suggest a hypothesis for neutropenia in these and other bone marrow failure syndromes: NE is a transmembrane """"""""cargo"""""""" protein for AP3. Mutation of NE's transmembrane domains causes too much NE to accumulate in granules, resulting in CN. Mutation of NE's AP3-recognition signal, or of AP3 itself, mislocalizes NE to the plasma membrane. Similarly, over-expression of NE consequent to ELA2 promoter variants or Gfi1 mutations overwhelms normal AP3-mediated trafficking pathways and diverts NE to the plasma membrane.
Three Specific Aims are directed toward testing this hypothesis, determining if a common ELA2 promoter variant in the African-American population associates with benign ethnic neutropenia, and identifying additional neutropenia genes: 1 Characterize NE's membrane relationship: 1.1 Develop antibodies to predicted cytoplasmic and luminal surfaces of NE; 1.2 Test membrane-bound NE for altered catalysis on model and biological substrates; 1.3 Examine the evolutionary conservation of AP3 interactions in other species and for other proteases. 2 Evaluate mistrafficking of NE as a general mechanism for neutropenia: 2.1 Identify potential substrates and cofactors of mislocalized NE; 2.2 Inspect NE trafficking in other neutropenic disorders. 3 Discover other mutations that may cause neutropenia through over-expression of NE: 3.1 Determine if ELA2 promoter variation contributes to neutropenia; 3.2 Measure the frequency of the ELA2 C-199A allele in individuals of African descent with benign ethnic neutropenia; 3.3 Identify new neutropenia genes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL079507-03
Application #
7105072
Study Section
Special Emphasis Panel (ZHL1-CSR-D (S1))
Program Officer
Qasba, Pankaj
Project Start
2004-09-30
Project End
2009-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
3
Fiscal Year
2006
Total Cost
$366,180
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wlodarski, Marcin W; Collin, Matthew; Horwitz, Marshall S (2017) GATA2 deficiency and related myeloid neoplasms. Semin Hematol 54:81-86
Salipante, Stephen J; Rojas, Meghan E B; Korkmaz, Brice et al. (2009) Contributions to neutropenia from PFAAP5 (N4BP2L2), a novel protein mediating transcriptional repressor cooperation between Gfi1 and neutrophil elastase. Mol Cell Biol 29:4394-405
Grann, Victor R; Ziv, Elad; Joseph, Cecil K et al. (2008) Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol 143:288-93
Michaud, Joelle; Simpson, Ken M; Escher, Robert et al. (2008) Integrative analysis of RUNX1 downstream pathways and target genes. BMC Genomics 9:363
Grann, Victor R; Bowman, Natalie; Joseph, Cecil et al. (2008) Neutropenia in 6 ethnic groups from the Caribbean and the U.S. Cancer 113:854-60
Duan, Zhijun; Person, Richard E; Lee, Hu-Hui et al. (2007) Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5. Mol Cell Biol 27:6889-902
Salipante, Stephen J; Benson, Kathleen F; Luty, Joanna et al. (2007) Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat 28:874-81
Horwitz, Marshall S; Duan, Zhijun; Korkmaz, Brice et al. (2007) Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 109:1817-24
Benson, Kathleen F; Horwitz, Marshall (2006) Familial leukemia. Best Pract Res Clin Haematol 19:269-79
Duan, Zhijun; Zarebski, Adrian; Montoya-Durango, Diego et al. (2005) Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol Cell Biol 25:10338-51

Showing the most recent 10 out of 11 publications